2-amino-4-{[2-({4-[3-(carboxymethyl)-4,6-dihydroxy-2-methoxyphenyl]-3-hydroxy-2-methylbutan-2-yl}sulfanyl)-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]ethyl]-C-hydroxycarbonimidoyl}butanoic acid

Metabolite details

Identifier

RZQHGPRGZNSTOU-UHFFFAOYSA-N

InChI Key

RZQHGPRGZNSTOU-UHFFFAOYSA-N

IUPAC name

2-amino-5-[[1-(carboxymethylamino)-3-[4-[3-(carboxymethyl)-4,6-dihydroxy-2-methoxyphenyl]-3-hydroxy-2-methylbutan-2-yl]sulanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

Preferred name

2-amino-4-{[2-({4-[3-(carboxymethyl)-4,6-dihydroxy-2-methoxyphenyl]-3-hydroxy-2-methylbutan-2-yl}sulfanyl)-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]ethyl]-C-hydroxycarbonimidoyl}butanoic acid

INN name

—

Synonym

—

ChEBI

CHEBI:185373

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Effects of Radiofrequency Field from 5G Communications on fecal microbiome and metabolome profiles in mice
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis

Observed in differential profiles

• Sham_vs_Radiofrequency
• Control_vs_ZYP_High_Dose